The study identifies 20 improvement ideas near the Kenwood Towne Centre, ranging from adding turn lanes on Kenwood Road to ...

Investigators from Shanghai, China, report responses above 90% by using levantinib and tislelizumab to treat patients with a ...

Symptom scores remained stable over time, with similar QOL trends in both treatment arms.

Among patients with clear cell renal cell carcinoma, improved responses were observed with Lenvima plus Welireg versus ...

Belzutifan plus cabozantinib maintained durable antitumor activity in advanced clear cell renal cell carcinoma, per phase 3 ...

Casas, MD, discusses a systematic review of recent trials examining objective response rate and adverse events of antibody drug conjugate (ADC) combinations in advanced urothelial cancer.

Racial bias in pain treatment continues to harm Black patients, exposing deep-rooted disparities in healthcare. Change is ...

Pfizer’s Talzenna in combi with Xtandi improves survival outcomes in metastatic castration resistant prostate cancer: New York Saturday, February 15, 2025, 11:00 Hrs [IST] Pfize ...

W hen it comes to sleep aids, the first one you probably think of is melatonin. While it's the most popular, melatonin doesn't work for everyone. From bizarre dreams to leaving yo ...

Hashtag, a weekly place for broader context. Saturday Hashtag: #TheBillionDollarFakeAcademicPropagandaMachine originally ...

Notably, Madhya Pradesh alone accounts for 1.58 million hectares of this increase, contributing two-thirds of the national total. A study by the National Institute of Agricultural Economics and Policy ...

GU ASCO annual meeting featured a kidney cancer trials in progress session and a presentation by Dr. Eric Jonasch discussing a phase 1b/2 study of combination 177Lu girentuximab + cabozantinib and ...